Stuart Clarke

Professor Stuart Clarke is a Professor of Medical Biology and Public Health at the University of Southampton, affiliated with the Department of Infection within the School of Clinical and Experimental Sciences, Faculty of Medicine. His research focuses on the epidemiology of vaccine-preventable infections, particularly pneumococcal diseases, and their public health implications. He has led multiple studies in Malaysia, Thailand, and the UK, collaborating with organizations like Pfizer, Merck, and the Bill & Melinda Gates Foundation.

His research interests include bacterial pathogen epidemiology, vaccine efficacy analysis, and the impact of non-pharmaceutical interventions on respiratory infections. Notable work includes genomic studies of Acinetobacter baumannii and Klebsiella pneumoniae, as well as evaluations of pneumococcal carriage dynamics in pediatric populations. He serves on the editorial board of the journal *Pneumonia* since 2020.

Professor Clarke's recent publications emphasize the interplay between bacterial migration patterns and public health strategies, including the effects of pandemic-related measures on pathogen transmission. His work bridges clinical microbiology and population health, addressing global health challenges such as antimicrobial resistance and vaccine implementation in resource-limited settings.

He was nominated for the Newton Prize 2017 (Malaysia) and has supervised numerous collaborative research initiatives. His lab focuses on translational research to inform policy and improve public health outcomes.